MTF Biologics

What it reported doing in 2024

Mtf is a global nonprofit organization focused on saving and healing lives, expanding innovation potential, honoring donated gifts and serving patients. Mtf continues to provide research tissue and grant funding for research and development performed by academic centers and pioneering enterprises.in 2024 mtf continued to pursue its mission, and made tissue forms available in the orthopedic, plastic and reconstructive surgery, and wound care markets through both internal and external distribution relationships. Mtf orthopedics fostered new partnerships and expanded (see schedule o)its reach by launching multiple new tissue forms in 2024. These innovations positioned the foundation and our partners to help more patients, while further maximizing the gift of donation. Mtf also implemented process efficiencies that will continue to utilize the gift of donation and allows our surgeon collaborators to elevate their continuum of care. In the plastic and reconstructive surgery division, mtf continued to innovate in plastic surgery, while providing surgeon education and training. Continued focus was placed on processing efficiencies and donor recovery methods to maximize the gift of donation with the help of organ procurement organizations. Mtf continued to bolster its inter-industry partnerships, increasing the availability of donated human tissue, and the ability to bring human tissue allografts to surgeons and patients. Mtf's wound care division continued growing throughout 2024, expanding its presence in the wound healing space.mtf generated more clinical efficacy data, as well as health care economic data for expanded reimbursement in wound care and plastic and reconstructive surgery procedures, further illustrating the safety and value of its tissue forms.during 2024, mtf maintained its commitment to advancing key programs, with significant investments in the following areas: tissue recovery and processing: $203,669,233tissue distribution: $228,708,012research and development: $15,307,466these efforts reflect mtf's ongoing dedication to supporting tissue donation, ensuring efficient distribution, and driving innovation through research.our goal is simple-do what's right for patients, surgeons, tissue donors, and their families through our guiding principles:1) we transform by providing safe, high-quality grafts from donated human tissues that are used in a growing array of clinical fields.2) we collaborate by forging relationships with experts in tissue and organ recovery, as well as leading physicians and scientists, to accelerate innovation and ensure the best possible experiences and outcomes for patients.3) we innovate by advancing the science of transplantation by supporting research within our own organization and among clinicians and researchers worldwide.4) we give back by reinvesting in research to positively affect lives across the globe. Since its inception in 1987, mtf, the nation's leading tissue bank, has received tissue donations from over 170,000 donors. In 2024, mtf recovered tissue from over 5,600 donors for use in musculoskeletal and bone allograft applications, over 7,500 donors for use in general, and plastic surgery applications, over 800 birth tissue donors for use predominantly in wound care applications and over 800 donors for organs and tissues for research. Overall, mtf distributed over 550,000 units of allograft tissue during 2024.mtf's mission is to save and heal lives by honoring the donated gift, serving patients and advancing science.for individual stories about donor families, please visit mtf biologics website at: https://www.mtfbiologics.org/who-we-serve/donorscommunity/ donors-families. Storiesabout recipients are also available on the website at: https://www.mtfbiologics.org/who-we-serve/donorscommunity/ recipients

Financial Efficiency

• Mission deployment rate: 87.6%; rating input score 88
• Program expense ratio: 91%; rating input score 91
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 93.8%; rating input score 94; 25th percentile among comparable filings
• Pay-setting controls: 5 of 6 controls in place; rating input score 83
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Pass
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Scored; rating input score 0
• Grant itemization coverage: 55.6%; rating input score 56; 11th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 80%; rating input score 80; 28th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 3.6%; rating input score 50; 50th percentile among comparable filings
• Total-asset coverage ratio: 0.66; rating input score 25; 25th percentile among comparable filings
• Liabilities to assets ratio: 0.61; rating input score 28; 28th percentile among comparable filings
• Officer compensation ratio: 1.6%; rating input score 63; 63rd percentile among comparable filings

Growth

• Program expense growth: 1% per year; rating input score 100; 10th percentile among comparable filings
• Revenue growth: 1.6% per year; rating input score 100; 12th percentile among comparable filings
• Asset growth: 2.7% per year; rating input score 100; 19th percentile among comparable filings